Soluble Syndecan-1 Levels Are Elevated in Patients with Inflammatory Bowel Disease

被引:0
作者
Doron Yablecovitch
Assaf Stein
Maytal Shabat-Simon
Timna Naftali
Gila Gabay
Ido Laish
Asaf Oren
Fred M. Konikoff
机构
[1] Meir Medical Center,Department of Gastroenterology and Hepatology
[2] Tel Aviv University,Department of Marketing, Management Faculty
[3] Tel Aviv Medical Center,Pediatric Endocrinology and Diabetes Unit, Dana
[4] Tel Aviv University,Dwek Children Hospital
来源
Digestive Diseases and Sciences | 2015年 / 60卷
关键词
Inflammatory bowel disease; Crohn’s disease; Ulcerative colitis; Soluble syndecan-1; Biomarker;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2419 / 2426
页数:7
相关论文
共 123 条
[1]  
Podolsky DK(2002)Inflammatory bowel disease N Engl J Med 347 417-429
[2]  
Principi M(2006)Differential immunohistochemical expression of syndecan-1 and tumor necrosis factor alpha in colonic mucosa of patients with Crohn’s disease Immunopharmacol Immunotoxicol 28 185-195
[3]  
Day R(2007)Molecular and cellular mechanisms of syndecans in tissue injury and inflammation Mol Cells 24 153-166
[4]  
Marangi S(1997)Syndecans: multifunctional cell-surface co-receptors Biochem J 327 1-16
[5]  
Bartlett AH(1999)Heparin, cell adhesion, and pathogenesis of inflammatory bowel disease Lancet 354 62-65
[6]  
Hayashida K(2003)Syndecans in inflammation Faseb J 17 575-591
[7]  
Park PW(2014)Mucosal expression of basic fibroblastic growth factor, syndecan 1 and tumour necrosis factor-alpha in Crohn’s disease in deep remission under treatment with anti-TNFalpha antibodies J Gastrointest Liver Dis 23 261-265
[8]  
Carey DJ(2012)Expression of heparan sulfate proteoglycans in murine models of experimental colitis Inflamm Bowel Dis 18 1112-1126
[9]  
Day R(2011)Infliximab therapy downregulation of basic fibroblast growth factor/syndecan 1 link: a possible molecular pathway of mucosal healing in ulcerative colitis J Clin Pathol 64 968-972
[10]  
Forbes A(1991)A dual receptor system is required for basic fibroblast growth factor activity Cell 67 229-231